Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.
about
The C Terminus of HIV-1 Tat Modulates the Extent of CD178-mediated Apoptosis of T CellsThe Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell ApoptosisMonitoring tat peptide binding to TAR RNA by solid-state 31P-19F REDOR NMRHomonuclear (1)H-NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal proteinThe HIV Tat protein affects processing of ribosomal RNA precursor.Recognition of HIV TAR RNA by triazole linked neomycin dimers.The bend in RNA created by the trans-activation response element bulge of human immunodeficiency virus is straightened by arginine and by Tat-derived peptideReservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine.Conformational analysis of the Campylobacter jejuni porinp53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation.What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?Viral factors in non-progression.TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer.RNA and DNA binding of inert oligonuclear ruthenium(II) complexes in live eukaryotic cells.Synthesis and RNA polymerase incorporation of the degenerate ribonucleotide analogue rPTP13C/15N-19F intermolecular REDOR NMR study of the interaction of TAR RNA with Tat peptides.Effects of human chromosome 12 on interactions between Tat and TAR of human immunodeficiency virus type 1.The HIV-1 Tat Protein Is Monomethylated at Lysine 71 by the Lysine Methyltransferase KMT7Stability of HIV-1 subtype B and C Tat is associated with variation in the carboxyl-terminal region.Deciphering structure-activity relationships in a series of Tat/TAR inhibitors.Identification of a highly conserved surface on Tat variants.Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.High yields and soluble expression of superoxide dismutases in Escherichia coli due to the HIV-1 Tat peptide via increases in mRNA transcription.Aqueous solution structure of a hybrid lentiviral Tat peptide and a model of its interaction with HIV-1 TAR RNA.Full peptide synthesis, purification, and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents.Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants.Superior HIV-1 TAR Binders with Conformationally Constrained R52 Arginine Mimics in the Tat(48-57) Peptide.TdIF2 is a nucleolar protein that promotes rRNA gene promoter activity.
P2860
Q22248066-F5A80016-31A4-4659-803A-DDF30B014F35Q22248069-40430AC3-B5C7-4C79-8F2D-03C8657B5A34Q24810413-0B0AC774-966D-44D6-99F2-661875102B4FQ27637986-154F5518-E57D-478A-824B-259310B27EAEQ33344221-C76EAB23-99DF-4535-8B57-B716999E348CQ33961121-A5AE8F61-10F7-4AD8-A870-E6D226F05266Q34180644-219FE612-967D-44E6-A513-8534AE19FE9AQ34488930-288CA88F-7BB4-4717-A7E2-E9E2D86D6487Q35591105-FC604CD7-FF42-424B-82D2-F93506706CB5Q35641069-BDA055DC-C8BB-4FAE-AA3E-66BE8FE32633Q35711994-7A7EDD7B-CEF8-4867-823C-219E9B3DFC62Q37220038-C831267C-4B36-4BCD-BB28-4EBCE85B810DQ37412098-818AD434-5FFF-4B87-BA1E-90ED9EA3E4ADQ38337003-BE37B35C-741B-4CD2-8374-9DE252162936Q38946136-EF467888-3333-41FB-8DBE-9FE441EE29D8Q39723627-A92C79D2-51F5-499C-B116-BD3364176F73Q39815224-E284F312-9CE7-45F1-B313-817545D265A2Q40041905-3FE2A72E-16E7-4AA3-9488-06CC79C908B0Q40731101-29F8C2CF-3E58-4C35-88D3-6FD73337B4C3Q40743714-131FA0B2-3728-462D-A0C9-1E375D058F5EQ41159138-130ECDBA-CE9D-47CE-AD16-7CAA27C7DD44Q41468434-068100E9-24B7-46EC-89CE-5C210B961378Q42010727-3481A5C9-559E-4728-AAC5-A56925EED76BQ42035733-746BFE9D-F3C6-4996-ACF4-19FBEF190D30Q46319992-6F383C49-747A-4C67-86E1-41FA3D839197Q46361892-5D239D78-F69A-4B63-956B-26F7C5A4F102Q46747253-ADD15A8D-287A-4D66-84A0-556279702D8BQ48285475-56EEB99E-B804-49AB-98A9-E124D5F42E22Q51548201-A8E5AAD6-20D8-429B-948C-551024EBD10C
P2860
Circular dichroism and molecular modeling yield a structure for the complex of human immunodeficiency virus type 1 trans-activation response RNA and the binding region of Tat, the trans-acting transcriptional activator.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circular dichroism and molecul ...... ing transcriptional activator.
@en
Circular dichroism and molecul ...... ing transcriptional activator.
@nl
type
label
Circular dichroism and molecul ...... ing transcriptional activator.
@en
Circular dichroism and molecul ...... ing transcriptional activator.
@nl
prefLabel
Circular dichroism and molecul ...... ing transcriptional activator.
@en
Circular dichroism and molecul ...... ing transcriptional activator.
@nl
P2093
P2860
P356
P1476
Circular dichroism and molecul ...... ing transcriptional activator.
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.20.9734
P407
P577
1992-10-01T00:00:00Z